The tumor’s mesenchymal origin necessitates the demonstration of smooth muscle differentiation through positivity for SMA, desmin, and caldesmon, while excluding other sarcoma subtypes and metastatic disease (14). Here, CALD1 is linked to metastatic neoplasm.